+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

From
Ibuprofen API - Global Strategic Business Report - Product Thumbnail Image

Ibuprofen API - Global Strategic Business Report

  • Report
  • May 2026
  • 139 Pages
  • Global
From
From
From
Gout Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gout Therapeutics - Global Strategic Business Report

  • Report
  • May 2026
  • 279 Pages
  • Global
From
Lupus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lupus Therapeutics - Global Strategic Business Report

  • Report
  • May 2026
  • 260 Pages
  • Global
From
From
From
From
Hydroxychloroquine - Global Strategic Business Report - Product Thumbnail Image

Hydroxychloroquine - Global Strategic Business Report

  • Report
  • May 2026
  • 293 Pages
  • Global
From
Corticosteroids Therapy - Global Strategic Business Report - Product Thumbnail Image

Corticosteroids Therapy - Global Strategic Business Report

  • Report
  • May 2026
  • 282 Pages
  • Global
From
Beta Interferon - Global Strategic Business Report - Product Thumbnail Image

Beta Interferon - Global Strategic Business Report

  • Report
  • May 2026
  • 138 Pages
  • Global
From
Glucosamine - Global Strategic Business Report - Product Thumbnail Image

Glucosamine - Global Strategic Business Report

  • Report
  • May 2026
  • 350 Pages
  • Global
From
Ocular Immunosuppressants Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ocular Immunosuppressants Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Autoimmune Gastrointestinal Dysmotility Market Report 2026 - Product Thumbnail Image

Autoimmune Gastrointestinal Dysmotility Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Systemic Juvenile Idiopathic Arthritis Market Report 2026 - Product Thumbnail Image

Systemic Juvenile Idiopathic Arthritis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Bispecific Antibodies - Competitive Landscape, 2026 - Product Thumbnail Image

Bispecific Antibodies - Competitive Landscape, 2026

  • Report
  • January 2026
  • 450 Pages
  • Global
From
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more